BioLineRx Ltd.
TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA

Last updated:

Abstract:

A method of treating metastatic pancreatic adenocarcinoma in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of each of a peptide set forth in SEQ ID NO: 1, an anti PD-1 and a chemotherapy, thereby treating the metastatic pancreatic adenocarcinoma.

Status:
Application
Type:

Utility

Filling date:

17 Oct 2019

Issue date:

13 Jan 2022